Edwards Lifesciences Corporation Share Price
Stocks
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Real-time Estimate
Cboe BZX
09:27:04 13/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 92.94 USD | -0.12% |
|
+4.39% | +9.38% |
| 06/08 | Carvolix Secures Up to €30m in Financing |  |
| 29/07 | Edwards Lifesciences Insider Sold Shares Worth $818,958, According to a Recent SEC Filing | MT |
| Market Cap | 5.36TCr 4.65TCr 4.35TCr 3.97TCr 7.47TCr 5,11600Cr 7.58TCr 51TCr 20TCr 2,56100Cr 20TCr 20TCr 8,54100Cr | P/E 2026 * |
36.8x | P/E 2027 * | 28.2x |
|---|---|---|---|---|---|
| Enterprise Value | 5TCr 4.33TCr 4.06TCr 3.7TCr 6.96TCr 4,76900Cr 7.07TCr 48TCr 19TCr 2,38800Cr 19TCr 18TCr 7,96300Cr | EV / Sales 2026 * |
7.4x | EV / Sales 2027 * | 6.52x |
| Free-Float |
86.96% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Edwards Lifesciences Corporation
| 1 day | -0.11% | ||
| 1 week | +4.39% | ||
| Current month | +8.34% | ||
| 1 month | +1.59% | ||
| 3 months | +14.57% | ||
| 6 months | +22.90% | ||
| Current year | +9.38% |
| 1 week | 88.6 |  | 93.91 |
| 1 month | 81.16 | | 93.91 |
| Current year | 74.66 | | 96.29 |
| 1 year | 72.3 | | 96.29 |
| 3 years | 58.93 | | 96.29 |
| 5 years | 58.93 | | 131.73 |
| 10 years | 27.04 | | 131.73 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 11/05/2023 | |
Theodora Mistras
DFI | Director of Finance/CFO | 43 | 29/05/2026 |
| Chief Tech/Sci/R&D Officer | 51 | 01/09/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 69 | 07/05/2024 | |
Kieran Gallahue
BRD | Director/Board Member | 62 | 10/02/2015 |
| Director/Board Member | 58 | 11/05/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 11/08/26 | Fiscal year | Executive/Senior Manager | 1,857 | 0.0003% | ||
| 30/07/26 | Sell | Executive/Senior Manager | -146 | 0.0000% | ||
| 28/07/26 | Fiscal year | Executive/Senior Manager | 28,884 | 0.0050% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.12% | +4.39% | +20.04% | +15.79% | 5.36TCr | |
| -0.35% | +3.77% | +24.15% | +11.39% | 22TCr | |
| -0.77% | +2.30% | -2.18% | -20.45% | 14TCr | |
| -0.26% | +7.28% | -16.88% | +31.41% | 14TCr | |
| +0.39% | +4.98% | -49.51% | +0.83% | 7.45TCr | |
| +0.03% | -0.15% | -16.01% | -17.13% | 5.01TCr | |
| +0.28% | +5.39% | +23.83% | +17.62% | 4.19TCr | |
| +0.34% | +4.45% | +40.65% | +44.78% | 4.09TCr | |
| +1.45% | +4.42% | -2.54% | +2.26% | 3.26TCr | |
| -0.10% | +0.98% | -21.80% | +24.65% | 3.26TCr | |
| Average | +0.11% | +3.90% | -0.02% | +11.11% | 8.36TCr | |
| Weighted average by Cap. | -0.14% | +4.42% | +1.35% | +9.01% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 675.92Cr 585.62Cr 548.7Cr 500.47Cr 940.89Cr 64TCr 955.35Cr 6.45TCr 2.52TCr 32TCr 2.54TCr 2.48TCr 1,07600Cr | 742.91Cr 643.66Cr 603.07Cr 550.07Cr 1.03TCr 71TCr 1.05TCr 7.09TCr 2.77TCr 35TCr 2.79TCr 2.73TCr 1,18300Cr |
| Net income | 143.52Cr 124.34Cr 116.5Cr 106.26Cr 199.77Cr 14TCr 202.84Cr 1.37TCr 535.61Cr 6.85TCr 538.84Cr 527.13Cr 23TCr | 189.67Cr 164.33Cr 153.97Cr 140.43Cr 264.02Cr 18TCr 268.08Cr 1.81TCr 707.86Cr 9.06TCr 712.13Cr 696.65Cr 30TCr |
| Net Debt | -363.09Cr -314.58Cr -294.74Cr -268.84Cr -505.42Cr -35TCr -513.19Cr -3.47TCr -1.36TCr -17TCr -1.36TCr -1.33TCr -58TCr | -519.47Cr -450.07Cr -421.69Cr -384.62Cr -723.1Cr -50TCr -734.22Cr -4.96TCr -1.94TCr -25TCr -1.95TCr -1.91TCr -83TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/26/13 | $93.39 | +0.37% | 3,72,249 |
| 12/26/12 | $93.05 | -0.65% | 23,40,306 |
| 11/26/11 | $93.66 | +1.77% | 31,38,661 |
| 10/26/10 | $92.03 | +2.57% | 44,43,994 |
| 07/26/07 | $89.72 | +0.45% | 24,42,024 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EW Stock
Select your edition
All financial news and data tailored to specific country editions
